Pulse Biosciences (PLSE) Work In Process (2021 - 2022)

Pulse Biosciences' quarterly Work In Process came in at $1.8 million in Q2 2022, up 6.68% quarter-over-quarter from $1.7 million in Q1 2022.

Pulse Biosciences has reported Work In Process for 2 years, with the latest figure at $1.8 million in Q2 2022.

  • For the quarter ending Q2 2022, Work In Process changed N/A year-over-year to $1.8 million; the trailing twelve-month figure through Jun 2022 stood at $1.8 million (changed N/A YoY), and the FY2021 full-year result was $1.4 million, changed N/A from the prior year.
  • Work In Process for Q2 2022 stood at $1.8 million, up from $1.7 million in the prior quarter.
  • The five-year high for Work In Process was $1.8 million in Q2 2022, with the low at $1.2 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Pulse Biosciences 1.72 Bn 1.72 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 1.79 Mn
Mar 31, 2022 1.68 Mn
Dec 31, 2021 1.37 Mn
Sep 30, 2021 1.22 Mn